期刊文献+

BIRC5 shRNA慢病毒表达载体的构建与鉴定 被引量:2

Construction and identification of BIRC5 shRNA lentiviral expression vector
下载PDF
导出
摘要 目的:应用RNA干扰技术,以人BIRC5基因为靶基因,设计合成3对短发夹结构的互补DNA序列和一对阴性对照序列,构建慢病毒干扰载体并鉴定。方法:将设计合成的单链引物退火成双链oligo序列,连接入经AgeI和EcoR I双酶切线性化的pMAGic慢病毒质粒载体中,经转化DH5α感受态细胞并筛选出阳性克隆,采用PCR扩增和DNA测序鉴定阳性克隆。结果:PCR扩增产物经凝胶电泳阳性克隆得到335 bp条带,阴性克隆得到298 bp条带,DNA测序结果证实其含设计合成序列。结论:4对BIRC5 shRNA重组慢病毒表达载体构建成功,为研究靶向BIRC5 siRNA对肿瘤细胞增殖抑制与诱导凋亡作用及基因治疗研究奠定了实验基础。 AIM:Design and synthesis complementary DNA sequences of 3 pairs of short hairpin structure and a pair of negative control sequence by RNA interference technique and construct and identify a lentiviral interference vector with human BIRC5 gene as target gene.METHODS:The designed and synthesised Single-Stranded primer were annealed to Double-Stranded oligo sequences and subcloned into linear pMAGic lentiviral plasmid vector digested by enzyme Age I and EcoR I.Screening positive clone after transformed into DH5α competent cells and identified by PCR amplification and DNA sequencing.RESULTS:335 bp straps of positive clone and 298 bp straps of negative clone form PCR amplification production have been obtained after gel electrophoresis,the designed and synthesised sequences have been contained in these clone straps confirmed by the result of DNA sequencing.CONCLUSION:Four pairs of BIRC5 shRNA recombinant lentiviral expression vector were constructed successfully,which laid the foundation for researching the inhibition of BIRC5 siRNA target against tumor cells proliferation,induction apoptosis and gene therapy.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2011年第7期767-769,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 陕西省社发攻关资助项目(2009K12-01)
关键词 RNA干扰 BIRC5 慢病毒表达载体 RNA interference BIRC5 lentiviral expression vector
  • 相关文献

参考文献9

  • 1Kamihira S, Yamada Y, Hirakata Y, et al. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukemia: surviving is an important determinant for prognosis[ J]. Br J Haematol, 2001, 14 (1) : 63 -69.
  • 2Ryan BM, Donovan N, Duffy MJ. Survivin: A new target for anti- cancer therapy [ J ]. Cancer Treat Rev, 2009, 35 (7) : 553 - 562.
  • 3Wang Q, Wu PC, Roberson RS. et al. Survivin and escaping in ther- apy-induced cellular senescence[J]. Int J Cancer, 2011, 128 (7) : 1546 - 1558.
  • 4Alper M, Cukur S, Belenli O, et al. Evaluation of the immunohisto- chemical stain patterns of surviving. Bak and Bag-1 in colorectal canc- ers and comparison with polyps situated in the colon [ J ]. Hepatogas- troenterology, 2008, 55 (85) : 1269 - 1273.
  • 5Chen T, Deng C. Inhibitory effect of siRNA targeting surviving in gas- tric cancer MGC-803 ceils [ J ]. Immunopharmacol, 2008, 8 ( 7 ) : 1006 - 1011.
  • 6Sun C, Cai M, Gunasekera AH, et al. NMR structure and mutage ne- sis of the inhibition of apopotosis protein XIAP [ J ]. Nature, 1999, 401 (6755) : 818 - 822.
  • 7Riedl S, Nicholson D, Rosen A, et al. Structural basis for the inhibi- tion of caspase-3 by XIAP[J]. Cell, 2001, 104(5): 791 -800.
  • 8Ghosal A, Kabir AH, Mandal A. RNA interference and its therapeutic potential[J]. Cen Eur J Med, 2011, 6(2) : 137 - 147.
  • 9Khaliq S, Jahan S, Ljaz B, et al. Inhibition of hepatitis C virus geno- type 3 a by siRNAs targeting envelope genes 1 [ J ]. Arch Virol, 2011, 156(3) : 433 -442.

同被引文献17

  • 1Nakagawa Y,Yamaguchi S,Hasegawa M,et al.Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia[J].Leukemia Research,2004,28(5):487-494.
  • 2Gradilone A,Gazzaniga P,Ribuffo D,et al.Survivin,bcl-2,bax,and bcl-X gene expression in sentinel lymph nodes from melanoma patients[J].Journal of Clinical Oncology,2003,21(2):306-312.
  • 3Olie RA,Hall J,Natt F,et al.Analysis of ribosyl-modified,mixed backbone analogs of a bcl-2/bcl-xL antisense oligonucleotide[J].Biochimica et Biophysica Acta,2002,1576(1/2):101-109.
  • 4Karlas A,Machuy N,Shin Y,et al.Genome-wide RNAi screen identifies human host factors crucial for influenza virus replicatin[J].Nature,2010,463(7282):818-822.
  • 5Kittler R,Pelletier L,Heninger AK,et al.Gemone-scale RNAi profiling of cell division in human tissue culture cells[J].Nat Cell Biol,2007,9(12):1401-1412.
  • 6Bjorklund M,Taipale M,Varjosalo M,et al.Identification of pathwarys regulating cell size and cell-cycle progression by RNAi[J].Nature,2006,439(7079):1009-1013.
  • 7Moffat J,Grueneberg DA,Yang X,et al.A lentiviral RNAi library for human and mouse gunes applied to an arrayed viral high-content screen[J].Cell,2006,124(6):1283-1298.
  • 8Krebs MD,Alsberg E.Localized,Targeted and Sustained siRNA Delivery[J].Chem Eur J,2011,17(11):3054-3062.
  • 9Xu CR,Lee SA,Chen X.RNA Interference as Therapeutics for Hepatocellular Carcinoma[J].Recent Pat Anticanc Drug Discov,2011,6(1):106-115.
  • 10Ghosal A,Kabir AH,Mandal A.RNA interference and its therapeutic potential[J].Cent Eur J Med,2011,6(2):137-147.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部